<DOC>
	<DOC>NCT00755352</DOC>
	<brief_summary>Determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on pravastatin therapy for at least 4 weeks.</brief_summary>
	<brief_title>A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Male or female &gt; or = to 18 years of age On a stable dose of pravastatin LDLC &gt; or = to 100 mg/dL and &lt; or = 250 mg/dL Triglycerides &lt; or = to 300 mg/dL Women are not pregnant or breastfeeding or planning to become pregnant Women have had a hysterectomy or tubal ligation, or who are postmenopausal or who practice an accepted method of birth control as specified in the protocol BMI &gt; 40 kg/m2 History of allergic or toxic reaction to colesevelam HCL History of swallowing disorder Any serious condition that would interfere with the conduct of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>